ADPT logo

Adaptive Biotechnologies (ADPT)

Profile

Full Name

Adaptive Biotechnologies Corporation

Ticker Symbol

ADPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 27, 2019

Indexes

Not included

Website

http://www.adaptivebiotech.com

Employees

619

Key Details

Price

$11.48(+2.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$178.96M(+5.10% YoY)

Annual EPS

-$1.08(+30.77% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.48
    ADPT price is $11.48

    30-Day Relative Volume

    0.67
    ADPT 30-day relative volume is 0.67

    Price Performance

    Price Most recent change

    +2.59%
    ADPT price was up +2.59% on Jul 2, 2025

    Price YTD change

    +91.49%
    ADPT price is up +91.49% since January 1st

    Price 1-year change

    +240.65%
    ADPT price is up +240.65% year-on-year

    Price 3-year change

    +36.34%
    ADPT price is up +36.34% over the past 3 years

    Price Range

    Price All-time high

    $71.25
    ADPT price is currently -83.89% below its historical high of $71.25

    Price 3-year low

    $2.28
    ADPT price is currently +403.51% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.74B
    ADPT market capitalization is $1.74 billion

    Market cap 3-year change

    +45.06%
    ADPT market capitalization is up +45.06% over the past 3 years

    Market cap All-time high

    $9.32B
    ADPT market capitalization is currently -81.30% below its historical high of $9.32 billion

    Market cap sector rank

    80.77%
    ADPT market capitalization is higher than 80.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.02%
    ADPT shares outstanding is up +3.02% year-on-year

    Shares Outstanding 3-Year Change

    +6.4%
    ADPT shares outstanding is up +6.4% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.62
    ADPT beta is 1.62

    200-day SMA

    $7.28
    ADPT price is currently +57.78% above its 200-day simple moving average

    50-day SMA

    $9.58
    ADPT price is currently +19.87% above its 50-day simple moving average

    RSI

    63.42
    ADPT 14-day relative strength index is 63.42

    Volume

    0.67
    ADPT 30-day relative volume is 0.67

    ATR

    $0.60
    ADPT average true range is $0.60

    10-day Historical Volatility

    72.62%
    ADPT 10-day historical volatility is 72.62%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $178.96M
    ADPT annual revenue is $178.96 million

    Revenue Analysts estimate

    $218.26M
    ADPT annual revenue is currently -18.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    +5.1%
    ADPT annual revenue is up +5.1% year-on-year

    Revenue Sector rank

    62.26%
    ADPT annual revenue is higher than 62.26% of companies in Healthcare sector

    EPS

    EPS

    -$1.08
    ADPT annual earnings per share is -$1.08

    EPS Analysts estimate

    -$0.84
    ADPT annual earnings per share is currently +28.27% higher than the consensus analysts' forecast

    EPS 1-year change

    +30.77%
    ADPT annual earnings per share is up +30.77% year-on-year

    EPS Sector rank

    54.12%
    ADPT annual earnings per share is higher than 54.12% of companies in Healthcare sector

    Profit

    Gross profit

    $106.88M
    ADPT annual gross profit is $106.88 million

    Gross margin

    59.72%
    ADPT annual gross profit margin is 59.72%

    Operating profit

    -$155.34M
    ADPT annual operating income is -$155.34 million

    Operating margin

    -86.81%
    ADPT annual operating profit margin is -86.81%

    Net income

    -$159.49M
    ADPT annual net profit is -$159.49 million

    Net margin

    -89.12%
    ADPT annual net profit margin is -89.12%

    Expenses

    Total expenses

    $334.30M
    ADPT annual total expenses is $334.30 million

    Operating expenses

    $262.22M
    ADPT annual total operating expenses is $262.22 million

    Cost of goods sold

    $72.08M
    ADPT annual cost of goods sold is $72.08 million

    Selling, general & administrative expenses

    $157.56M
    ADPT annual SGA is $157.56 million

    Depreciation and amortization

    $19.26M
    ADPT annual depreciation & amortization is $19.26 million

    Interest expense

    $11.58M
    ADPT annual interest expense is $11.58 million

    Income tax

    -
    ADPT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$148.01M
    ADPT annual earnings before interest & taxes is -$148.01 million

    EBITDA

    -$146.31M
    ADPT annual EBITDA is -$146.31 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $539.38M
    ADPT annual total assets is $539.38 million

    Non current assets

    $255.62M
    ADPT annual long term assets is $255.62 million

    Current assets

    $283.75M
    ADPT annual total current assets is $283.75 million

    Cash and cash equivalents

    $47.92M
    ADPT annual cash & cash equivalents is $47.92 million

    Accounts receivable

    $41.73M
    ADPT annual accounts receivable is $41.73 million

    Inventory

    $8.44M
    ADPT annual inventory is $8.44 million

    Liabilities

    Total liabilities

    $336.89M
    ADPT annual total liabilities is $336.89 million

    Long term liabilities

    $238.84M
    ADPT annual total long term liabilities is $238.84 million

    Current liabilities

    $98.05M
    ADPT annual total current liabilities is $98.05 million

    Accounts payable

    $7.26M
    ADPT annual accounts payable is $7.26 million

    Debt

    Total debt

    $89.39M
    ADPT annual total debt is $89.39 million

    Total debt 1-year change

    -9.5%
    ADPT annual total debt is down -9.5% year-on-year

    Long term debt

    $79.15M
    ADPT annual long term debt is $79.15 million

    Short term debt

    $10.24M
    ADPT annual short term debt is $10.24 million

    Equity & Capital

    Shareholders equity

    $202.71M
    ADPT annual stockholders equity is $202.71 million

    Book value

    $202.71M
    ADPT annual book value is $202.71 million

    Retained earnings

    -$1.30B
    ADPT annual retained earnings is -$1.30 billion

    Working capital

    $185.70M
    ADPT annual working capital is $185.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$95.21M
    ADPT annual cash flow from operations is -$95.21 million

    Cash from operations 1-year change

    +39.09%
    ADPT annual cash flow from operations is up +39.09% year-on-year

    Cash from investing

    $77.79M
    ADPT annual cash flow from investing activities is $77.79 million

    Cash from investing 1-year change

    -40%
    ADPT annual cash flow from investing activities is down -40% year-on-year

    Cash from financing

    $241.00K
    ADPT annual cash flow from financing activities is $241.00 thousand

    Cash from financing 1-year change

    -89.27%
    ADPT annual cash flow from financing activities is down -89.27% year-on-year

    CAPEX

    CAPEX

    $3.66M
    ADPT annual capital expenditures is $3.66 million

    CAPEX 1-year change

    -65.75%
    ADPT annual capital expenditures is down -65.75% year-on-year

    Free Cash Flow

    Free cash flow

    -$98.88M
    ADPT annual free cash flow is -$98.88 million

    Free cash flow 1-year change

    +40.8%
    ADPT annual free cash flow is up +40.8% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    59.72%
    ADPT annual gross profit margin is 59.72%

    Operating margin

    -86.81%
    ADPT annual operating profit margin is -86.81%

    Net margin

    -89.12%
    ADPT annual net profit margin is -89.12%

    ROA & ROE

    ROA

    -26.57%
    ADPT annual return on assets is -26.57%

    ROE

    -62.45%
    ADPT annual return on equity is -62.45%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ADPT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ADPT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    9.16
    ADPT price to book ratio is 9.16

    PB ratio Sector rank

    89.35%
    ADPT price to book ratio is higher than 89.35% of companies in Healthcare sector

    PS Ratio

    PS ratio

    9.20
    ADPT price to sales ratio is 9.20

    PS ratio Sector rank

    76.42%
    ADPT price to sales ratio is higher than 76.42% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.78B
    ADPT enterprise value is $1.78 billion

    Enterprise value Sector rank

    80.03%
    ADPT enterprise value is higher than 80.03% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -15.95
    ADPT EV/EBITDA is -15.95

    EV/EBITDA Sector rank

    9.41%
    ADPT EV/EBITDA is higher than 9.41% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.89
    ADPT annual current ratio is 2.89

    Quick ratio

    2.81
    ADPT annual quick ratio is 2.81

    Leverage

    Debt to equity

    0.00
    ADPT annual debt to equity ratio is 0.00

    Interest coverage ratio

    -12.78
    ADPT annual interest coverage ratio is -12.78

    Risk & Stability

    Piotroski F-Score

    4
    ADPT piotroski f-score is 4

    Altman Z-Score

    -0.44
    ADPT altman z-score is -0.44

    Analyst ratings

    Recent major analysts updates

    Jun 18, 25 Craig-Hallum
    Buy
    May 6, 25 Piper Sandler
    Overweight
    May 5, 25 Morgan Stanley
    Equal-Weight
    May 2, 25 Goldman Sachs
    Buy
    Mar 21, 25 Goldman Sachs
    Buy
    Feb 20, 25 Piper Sandler
    Overweight
    Feb 13, 25 Scotiabank
    Sector Outperform
    Jan 28, 25 Goldman Sachs
    Neutral
    Dec 18, 24 BTIG
    Buy
    Nov 11, 24 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with ADPT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Adaptive Biotechnologies?
    • Does Adaptive Biotechnologies pay dividends?
    • What sector is Adaptive Biotechnologies in?
    • What industry is Adaptive Biotechnologies in?
    • What country is Adaptive Biotechnologies based in?
    • When did Adaptive Biotechnologies go public?
    • Is Adaptive Biotechnologies in the S&P 500?
    • Is Adaptive Biotechnologies in the NASDAQ 100?
    • Is Adaptive Biotechnologies in the Dow Jones?
    • When was Adaptive Biotechnologies's last earnings report?
    • When does Adaptive Biotechnologies report earnings?
    • Should I buy Adaptive Biotechnologies stock now?

    What is the ticker symbol for Adaptive Biotechnologies?

    The ticker symbol for Adaptive Biotechnologies is NASDAQ:ADPT

    Does Adaptive Biotechnologies pay dividends?

    No, Adaptive Biotechnologies does not pay dividends

    What sector is Adaptive Biotechnologies in?

    Adaptive Biotechnologies is in the Healthcare sector

    What industry is Adaptive Biotechnologies in?

    Adaptive Biotechnologies is in the Biotechnology industry

    What country is Adaptive Biotechnologies based in?

    Adaptive Biotechnologies is headquartered in United States

    When did Adaptive Biotechnologies go public?

    Adaptive Biotechnologies's initial public offering (IPO) was on June 27, 2019

    Is Adaptive Biotechnologies in the S&P 500?

    No, Adaptive Biotechnologies is not included in the S&P 500 index

    Is Adaptive Biotechnologies in the NASDAQ 100?

    No, Adaptive Biotechnologies is not included in the NASDAQ 100 index

    Is Adaptive Biotechnologies in the Dow Jones?

    No, Adaptive Biotechnologies is not included in the Dow Jones index

    When was Adaptive Biotechnologies's last earnings report?

    Adaptive Biotechnologies's most recent earnings report was on May 1, 2025

    When does Adaptive Biotechnologies report earnings?

    The next expected earnings date for Adaptive Biotechnologies is Aug 1, 2025

    Should I buy Adaptive Biotechnologies stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page